How has been the historical performance of Dr Reddy's Labs?

Answer:The historical performance of Dr Reddy's Labs shows a consistent growth trajectory in net sales and profits over the years.

Breakdown:
Dr Reddy's Labs has demonstrated significant growth in net sales, increasing from 15,448.20 Cr in Mar'19 to 32,643.90 Cr in Mar'25. This upward trend is mirrored in total operating income, which also rose from 15,448.20 Cr to 32,643.90 Cr during the same period. The company's operating profit (PBDIT) has similarly improved, climbing from 3,515.70 Cr in Mar'19 to 9,644.40 Cr in Mar'25, although the operating profit margin has fluctuated, peaking at 28.42% in Mar'24 before settling at 26.26% in Mar'25. Profit before tax has followed suit, increasing from 2,292.00 Cr in Mar'19 to 7,657.80 Cr in Mar'25, while profit after tax reached 5,703.50 Cr in Mar'25, up from 1,906.20 Cr in Mar'19. The company's total assets have also expanded significantly, from 22,005.40 Cr in Mar'20 to 47,594.10 Cr in Mar'25, indicating robust growth in both current and non-current assets. Total liabilities increased from 22,005.40 Cr in Mar'20 to 47,594.10 Cr in Mar'25, reflecting the company's expanding operations. Cash flow from operating activities has shown a positive trend, with 4,642.00 Cr in Mar'25 compared to 2,984.00 Cr in Mar'20, while net cash inflow improved to 748.00 Cr in Mar'25 from a net outflow of 26.00 Cr in Mar'20. Overall, Dr Reddy's Labs has exhibited strong financial performance and growth across multiple metrics over the years.